athenahealth (athenahealth) GF Value : $0.00 (As of Apr. 26, 2024)

View and export this data going back to 2007. Start your Free Trial

What is athenahealth GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-04-26), athenahealth's share price is $9.95. athenahealth's GF Value is $0.00. Therefore, athenahealth's Price-to-GF-Value for today is .

Based on the relationship between the current stock price and the GF Value, GuruFocus believes athenahealth is Not Valued.

athenahealth (NAS:ATHN) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

athenahealth's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	9.95	/	0.00
	=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

athenahealth GF Value Related Terms

Thank you for viewing the detailed overview of athenahealth's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

athenahealth (athenahealth) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » athenahealth Inc (NAS:ATHN) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.athenahealth.com

Athenahealth provides healthcare IT (HCIT) services through cloud-based and mobile application products largely for smaller to midsize medical groups and health systems. Their services include revenue cycle and practice management, electronic health records, patient engagement, population health management, and care coordination. The business services segment generates 96% of revenue, which provides cloud-based solutions and support to healthcare providers. Athenahealth is headquartered in Waltham, Massachusetts.

Executives

Brian P Mckeon	director	IDEXX LABORATORIES, ONE IDEXX DRIVE, WESTBROOK ME 04092
John A Kane	director	C/O MERCHANTS BANCSHARES, INC., 275 KENNEDY DRIVE, SOUTH BURLINGTON VT 05403
Dev Ittycheria	director	C/O MONGO DB, INC., 1633 BROADWAY, 38TH FLOOR, NEW YORK NY 10019
Ed Park	director	311 ARSENAL STREET WATERTOWN MA 02472
Brandon H Hull	director	221 NASSAU STREET, PRINCETON NJ 08542
Thomas J Szkutak	director	P O BOX 81226, SEATTLE WA 98108-1226
Jeffrey R Immelt	director, other: Executive Chairman	GENERAL ELECTRIC COMPANY, 41 FARNSWORTH STREET, BOSTON MA 02210
Marc A Levine	officer: Chief Financial Officer	C/O ATHENAHEALTH, INC., 311 ARSENAL STREET, WATERTOWN MA 02472
Jacqueline B Kosecoff	director	5960 HEISLEY ROAD, MENTOR OH 44060
Amy Abernethy	director	311 ARSENAL STREET, WATERTOWN MA 02472
Kristi Ann Matus	officer: EVP and CFAO	C/O EQUITABLE HOLDINGS, INC., 1290 AVENUE OF THE AMERICAS, NEW YORK NY 10104
Daniel H. Orenstein	officer: SVP, GC, and Secretary	311 ARSENAL STREET, WATERTOWN MA 02472
Jeremy Delinsky	officer: SVP, Chief Product Officer	C/O WAYFAIR INC., 4 COPLEY PLACE, 7TH FLOOR, BOSTON MA 02116
Timothy M Adams	officer: CFO & SVP	311 ARSENAL STREET, WATERTOWN MA 02472
Bryan E Roberts	director	C/O VENROCK ASSOCIATES, 2494 SAND HILL ROAD STE 200, MENLO PARK CA 94025